Home › Atrial Fibrillation › North Carolina › Winston-Salem
Atrial Fibrillation clinical trials in Winston-Salem, NC
5 studies for Atrial Fibrillation are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Wake Forest Baptist Health, Winston-Salem
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Novant Health Forsyth Medical Center, Winston-Salem
Tracking Results of Ablations to Combat AF Registry Generation 2
RecruitingObservational study
- Atrium Health Wake Forest Baptist, Winston-Salem
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Forsyth Medical Center, Winston-Salem
- Wake Forest Baptist Medical Center, Winston-Salem
Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
Recruiting
- Wake Forest Health Sciences, Winston-Salem
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Orlando, FL9 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.